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Fast amoeboid migration is critical for developmental processes and can be hijacked by cancer cells to enhance metastatic
dissemination. This migratory behavior is tightly controlled by high levels of actomyosin contractility, but how it is coupled to
other cytoskeletal components is poorly understood. Septins are increasingly recognized as novel cytoskeletal components,
but details on their regulation and contribution to migration are lacking. Here, we show that the septin regulator Cdc42EP5 is
consistently required for amoeboid melanoma cells to invade and migrate into collagen-rich matrices and locally invade and
disseminate in vivo. Cdc42EP5 associates with actin structures, leading to increased actomyosin contractility and amoeboid
migration. Cdc42EP5 affects these functions through SEPT9-dependent F-actin cross-linking, which enables the generation of
F-actin bundles required for the sustained stabilization of highly contractile actomyosin structures. This study provides
evidence that Cdc42EP5 is a regulator of cancer cell motility that coordinates actin and septin networks and describes a
unique role for SEPT9 in melanoma invasion and metastasis.
Introduction
Malignantmelanoma is a very aggressive type of skin cancer due
to its highly metastatic behavior, which relies on the increased
ability of melanoma cells to migrate and invade (Lo and Fisher,
2014). Melanoma cells can migrate as single cells that display
two major morphologies: elongated mesenchymal or rounded
amoeboid. Mesenchymal migration is characterized by Rac-
driven actin-based protrusions, matrix degradation, and strong
focal adhesions (FAs) coupled to actin fibers that enable trans-
mission of forces (Pandya et al., 2017). In contrast, amoeboid
migration modes are characterized by a rounded morphology as
well as blebs, lower levels of adhesion, and high levels of acto-
myosin contractility (Paluch et al., 2016). Amoeboid migration
plays important roles in developmental processes and immune
cell function (Madsen and Sahai, 2010; Richardson and Lehmann,
2010). Additionally, amoeboid behavior is prominent in the in-
vasive fronts of melanomas in animal models (Herraiz et al., 2015;
Sanz-Moreno et al., 2008, 2011) and human lesions (Georgouli
et al., 2019; Orgaz et al., 2014; Sanz-Moreno et al., 2011). It has
also been associated with increased risk of metastasis and
poorer prognosis (Georgouli et al., 2019), which underlies the
need for a better mechanistic understanding of the process.
Actomyosin contractility driven by the motor protein myosin
II is critical for rounded migration (Tozluoğlu et al., 2013).
This process has been shown to be tightly controlled by Rho-
ROCK signaling leading to increased phosphorylation of the
regulatory myosin light chain 2 (MLC2; Vicente-Manzanares
et al., 2009). However, how actin structures are organized
and coordinated with other cytoskeletal components to enable
their correct assembly and the formation of fully functional
actomyosin networks is not well understood.
Septins are a large conserved family of GTP-binding proteins
that participate in a broad spectrum of cellular functions
(Mostowy and Cossart, 2012). Septins have been proposed as the
fourth component of the cytoskeleton due to their ability to form
higher-order structures such as filaments, which can associate
with distinct subsets of actin filaments andmicrotubules, as well
as membranes of specific curvature and composition (Spiliotis,
2018). Importantly, septins are emerging as crucial regulators of
the generation, maintenance, and positioning of cytoskeletal
networks with potential roles in cell migration. In line with this,
different septins have been shown to be required for mesen-
chymal migration in epithelial and endothelial cells (Dolat et al.,
2014; Liu et al., 2014). In addition, septins form a uniform net-
work at the cell cortex in leukocytes, and SEPT7 expression is
required for rapid cortical contraction during dynamic shape
changes (Gilden et al., 2012; Tooley et al., 2009). In cancer, a po-
tential role for septins in modulating aggressiveness is also start-
ing to emerge (Angelis and Spiliotis, 2016; Poüs et al., 2016),
although little is known about the molecular details and functions
of individual members in melanoma and amoeboid migration.
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Although a role for septins in modulating cytoskeletal re-
arrangements is clearly emerging, the regulatory mechanisms
required for establishing and maintaining these interactions in
migratory cells are still elusive. Binder of Rho GTPases (Borg)
proteins (also called Cdc42 effector proteins [Cdc42EPs]) are
among the few proteins known to interact with septins and
regulate their function (Farrugia and Calvo, 2016). Borg proteins
vary in length, but all contain a Borg homology 3 domain (BD3)
that binds septins (Farrugia and Calvo, 2016). Although they
remain largely uncharacterized, recent studies suggest crucial
roles of Borg proteins in regulating cytoskeletal organization and
related cellular processes (Calvo et al., 2015; Liu et al., 2014). Yet
the exact role of Borg proteins and septins inmigration and their
relationship in modulating cancer cell invasion and metastatic
dissemination remain to be determined.
Here, we investigate the contribution of individual Borg
proteins to rounded-amoeboid cell migration and invasion using
melanoma models. We find that Cdc42EP5 is consistently re-
quired for these processes in vitro and for local invasion
and metastasis in vivo. Mechanistically, we demonstrate that
Cdc42EP5 acts by inducing actin cytoskeleton rearrangements
that potentiate actomyosin function in a septin-dependent
manner, and we show a unique role for SEPT9 in controlling
actomyosin contractility, migration, and invasion.
Results
Identification of CDC42EP5 as a regulator of melanoma
migration, invasion, and metastasis
To assess the relevance of Borg proteins Cdc42ep1–Cdc42ep5 in
cancer cell migration and invasion, we first analyzed transwell
migration after RNAi silencing of individual genes in the murine
melanoma model 690.cl2 (Dhomen et al., 2009; Kümper et al.,
2016). Note that when referring to murine RNA/proteins, we
use an uppercase letter followed by all lowercase letters
(i.e., Cdc42ep5 or abbreviated forms [Ep5]), and when referring
to human products or in general, we use uppercase letters
(i.e., CDC42EP5 or EP5). We achieved knockdown of all Borg
genes when each gene was specifically targeted (Fig. S1 A).
Fig. 1 A shows that knocking down Cdc42ep3 and Cdc42ep5
significantly reduced the ability of 690.cl2 cells to migrate
through transwell pores, whereas silencing Cdc42ep2 increased
migration. To assess how these defects were affecting the ability
of melanoma cells to invade, we employed collagen invasion
assays and observed that only Cdc42ep5 depletion significantly
reduced 690.cl2 invasion (Fig. 1 B). Silencing Cdc42ep5 expres-
sion with two independent RNAis in 690.cl2 cells (Fig. 1 C)
yielded similar results (Fig. 1, D and E). Using CRISPR-Cas9
technology (Fig. S1, B and C), we generated Cdc42ep5-knockout
(KO) 690.cl2 cells expressing GFP (690.cl2KO-GFP) and knockout
cells ectopically reexpressing an N-terminal GFP-Cdc42ep5 fu-
sion (690.cl2KO-GFP-Cdc42ep5). Critically, GFP-Cdc42ep5 ex-
pression in the reconstituted 690.cl2KO cells was similar to
endogenous Cdc42ep5 levels in parental 690.cl2 cells. Functional
characterization informed that Cdc42ep5 depletion affected
melanoma migration in vitro and that these defects were abro-
gated when Cdc42ep5 expression was reconstituted (Fig. S1 D).
There was also a significant increase in the migratory abilities of
parental 690.cl2 cells after Cdc42ep5 overexpression (Fig. S1 E),
confirming a role for this protein in melanoma migration and
invasion in vitro. These results were further validated in an al-
ternative human melanoma model (WM266.4) and a model of
metastatic breast cancer (MDA-MB-231-LM2), where CDC42EP5
was consistently required for migration and invasion (Fig. S1,
F–H). We observed that Cdc42ep5/CDC42EP5 expression was
consistently low when compared with other Borg genes in all
these systems (Fig. S1, I and J), indicating that its relevance is not
a result of increased levels or abundance.
Melanoma cells can invade locally and disseminate to distant
organs including the lungs (Calvo et al., 2011). To confirm the
requirement for CDC42EP5 in these processes in vivo, we first
investigated lung metastasis after tail vein injection of control
and Cdc42ep5-knockdown 690.cl2 cells in mice (Fig. 1 F). 2 h
after injection, equal numbers of control and Cdc42ep5-depleted
cells lodged in the lungs (Fig. 1 G), indicating that Cdc42ep5 did
not affect survival in circulation. However, after 24 h, the
number of Cdc42ep5-knockdown cells that invaded into the lung
parenchyma was significantly reduced when compared with
control cells, confirming a role for Cdc42ep5 in metastatic
colonization in vivo. Next, we investigated melanoma motility
and local invasion using intravital imaging in living tumors
(Fig. 1 H). For this long-term assay, we employed the CRISPR-
engineered cell lines 690.cl2KO-GFP and 690.cl2KO-GFP-
Cdc42ep5, which will allow for assessing the specific role of
Cdc42ep5 and discard clonal effects derived from knockout
generation. No changes in melanoma proliferation or tumor
growth were observed after modulating Cdc42ep5 expression
(Fig. S1, K and L). Intravital imaging showed an increase in the
speed of moving cells in 690.cl2KO-GFP-Cdc42ep5 cells when
compared with 690.cl2KO-GFP cells (Fig. 1, I and J; and Videos
1 and 2). Together, these results indicate that CDC42EP5 is
consistently required for melanoma migration and invasion
in vitro and for local invasion and metastatic dissemination
in vivo.
CDC42EP5 promotes actomyosin function in collagen-rich
matrices
Fast motility of melanoma cells in vivo has been associated with
a particular rounded-amoeboid behavior that promotes local
invasion and metastasis, negatively impacting patient survival
(Sanz-Moreno et al., 2008; Sanz-Moreno andMarshall, 2010). In
melanoma, amoeboid migration in vivo is tightly regulated by
actomyosin function (Herraiz et al., 2015; Sanz-Moreno et al.,
2008, 2011). Importantly, rounded-amoeboid behavior in mela-
noma can be modeled in vitro by seeding cells on collagen-rich
matrices and assessing cell morphology and actomyosin function
(Sahai and Marshall, 2003; Sanz-Moreno et al., 2008).
To explore whether CDC42EP5 was promoting migration
and invasion by participating in these processes, we first used
confocal microscopy to determine the precise localization of
Cdc42ep5 with respect to actomyosin networks in 690.cl2 cells
seeded on collagen-rich matrices. We could not identify
suitable Cdc42ep5 antibodies for immunofluorescence, so we
stably expressed our GFP-Cdc42ep5 construct in 690.cl2 cells
Farrugia et al. Journal of Cell Biology 2 of 19
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Figure 1. Directed siRNA screen identifies CDC42EP5 as a new regulator of melanoma migration and invasion. (A) Images show DAPI staining of
migrated 690.cl2 murine melanoma after transfection with control (siCtr) or Cdc42ep1-5 (siEp1-5) siRNA. Scale bars, 1 mm. Graph shows fold migration. Bars
indicate mean ± SEM (n = 3 independent experiments; one-way paired ANOVA, Dunnett’s test: †, not significant; *, P < 0.05). (B) Images show F-actin (green)
and DAPI (blue) staining of 690.cl2 cells at different levels of collagen invasion after transfection with indicated siRNAs. Scale bars, 100 µm. Graph shows fold
Farrugia et al. Journal of Cell Biology 3 of 19
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to investigate its cellular localization. Initial analyses informed
that individual cells presented different degrees of Cdc42ep5
expression, which were positively correlated with actomyosin
function (as measured by pS19-MLC2 intensity levels), F-actin
levels, and cell roundness, suggesting a potential role for Cdc42ep5
in regulating these parameters (Fig. S2, A and B). In-depth
confocal analysis of Cdc42ep5-expressing rounded 690.cl2
cells on collagen-rich matrices informed that GFP-Cdc42ep5
localized preferentially at the cell cortex (Fig. 2 A), colocaliz-
ing with two key components of cortical actomyosin networks,
F-actin and pS19-MLC2.
A role for CDC42EP5 in modulating actomyosin contractility
in 3D was further confirmed by perturbation analyses. Thus,
silencing Cdc42ep5 with two independent RNAis significantly
decreased the roundness index of 690.cl2 cells seeded on
collagen-rich matrices (Fig. 2, B and C; and Fig. S2, C and D).
Importantly, the reduction in cell rounding after Cdc42ep5 de-
pletion was associated with a decrease in F-actin and pS19-MLC2
levels by immunofluorescence (Fig. 2, B and C). Immunoblot
analyses of whole-cell lysates confirmed the reduction of pS19-
MLC2, but not total MLC2, levels after Cdc42ep5 silencing
(Fig. 2 D). As a result, the ability of cells to contract collagen-rich
matrices was severely impeded after Cdc42ep5 depletion (Fig. 2
E), which underlines the relevance of Cdc42ep5 in modulating
actomyosin activity and cellular contractility. The association
between cell rounding and CDC42EP5 expression was consistent
in other melanoma cell lines. Thus, we found that CDC42EP5 was
the only Borg genewhose expressionwas significantly correlated
with cell roundness (as assessed on cells seeded on collagen-rich
matrices) in a panel of 11 human melanoma cell lines of varying
degrees of rounding (Orgaz et al., 2014; Figs. 2 F and S2 E).
Perturbation analyses confirmed this observation, as silencing
Borg genes CDC42EP1–CDC42EP4 in 690.cl2 had no effect on
pS19-MLC2 levels, which contrasted with the significant de-
crease after CDC42EP5 depletion (Fig. S2 F). Together, these data
indicated that CDC42EP5 promotes the generation of an acto-
myosin cortex, which impacts actomyosin activity and cell
morphology, and induces invasive phenotypes in melanoma
cells in 3D settings.
CDC42EP5 regulates the organization of actomyosin networks
and is required for the maturation of FAs
While actomyosin contractility in 3D pliable environments
drives rounded-amoeboid behavior, in stiff undeformable 2D
culture, it can be associated with the formation of stress fibers,
long actin filaments decorated with active MLC2 (pS19-MLC2;
Pellegrin and Mellor, 2007). To assess if actomyosin was regu-
lated by Cdc42ep5 independently of the physical context, we
next used 2D culture. We observed that Cdc42ep5 formed an
intricate filamentous network that overlapped fibrillar actin
bundles in the perinuclear region in 690.cl2 cells (Fig. 3 A).
Cdc42ep5 filaments were less evident toward the cell periphery.
Time-lapse imaging showed that Cdc42ep5 filaments were dy-
namic and aligned with F-actin fibers, stretching along the cell
body toward the cell periphery (Video 3). Cdc42ep5 filaments
were absent from lamellipodial regions and membrane ruffles.
In agreement, Pearson’s correlation analyses informed that
Cdc42ep5 colocalized with F-actin preferentially in the perinu-
clear region in fixed cells (Fig. 3, A and B). There was no co-
localization of GFP-Cdc42ep5 with acetylated α-tubulin; therefore,
direct associations between Cdc42ep5 and microtubules were
unlikely (Figs. S3 A and 3 B). More detailed analyses of cellular
structures in 2D informed that GFP-Cdc42ep5 filaments aligned
with both F-actin– and pS19-MLC2–positive filaments (i.e., stress
fibers; Fig. S3 B). In cellular protrusions, Cdc42ep5 localized with
actomyosin filaments mostly around the edges of the protrusion.
Confocal analysis of the perinuclear region indicated that
Cdc42ep5 filaments stretched across the basal side in alignment
with F-actin fibers, with activated MLC2 dotted around the network.
Cdc42ep5 also localized in the apical region, where it formed a “wavy”
network around actomyosin filaments.
To establish a causal connection between Cdc42ep5 filaments
and actomyosin structures in 2D, Cdc42ep5 expression was si-
lenced in 690.cl2 cells using two independent RNAis. Cdc42ep5
knockdown severely affected F-actin organization, as actin
stress fibers were completely disrupted, especially at the peri-
nuclear region (Fig. 3 C). In contrast, the meshwork pattern of
fibrillar actin at the cell periphery was not affected, although
actin in the lamellipodial areas appeared thinner and more
condensed. This result showed that Cdc42ep5 was particularly
required for stress fiber stabilization. Importantly, CDC42EP5-
associated phenotypes were extensible to other cell types, as
similar results were obtained after depletion of CDC42EP5 in
human melanoma cells (WM266.4) and in murine embryonic
fibroblasts (Fig. S3 C). These data suggest that CDC42EP5 is a
conserved regulator of the actomyosin cytoskeleton.
The actomyosin complex is critical for the growth and
elongation of cell–ECM adhesions required for efficient cell
invasion. Bars indicate mean ± SEM (n = 3 independent experiments; one-way paired ANOVA, Dunnett’s test: †, not significant; #, P < 0.0001). (C) Repre-
sentative Western blot showing indicated protein levels in 690.cl2 cells after transfection with control (siCtr) or two individual Cdc42ep5 (siEp5) siRNAs. Graph
shows quantification of Cdc42ep5 protein levels. Bars indicate mean ± SEM (n = 3 experiments; one-way paired ANOVA, Dunnett’s test; *, P < 0.05; **, P <
0.01). (D) Fold migration of 690.cl2 cells after transfection with indicated siRNAs. Bars indicate mean ± SEM (n = 3 independent experiments; one-way paired
ANOVA, Dunnett’s test: *, P < 0.05; **, P < 0.01). (E) Images show 3D reconstructions of collagen invasion assays of 690.cl2 cells transfected with indicated
siRNAs. Color scale bar indicates depth of invasion. (F) Experimental metastasis approach. Equal numbers of control (siCtr, red) and Cdc42ep5-knockdown
(siEp5, green) 690.cl2 cells were injected in the tail vein of mice. 2 and 24 h after injection, lungs were analyzed by microscopy. (G) Images of mouse lungs at
2 and 24 h after tail injection with 690.cl2 cells as in F. Scale bars, 100 µm. Graph shows proportions (%) of siCtr and siEp5 cells in lungs at 24 h. Lines represent
mean ± SEM (n = 5 experiments; unpaired t test). (H) Intravital imaging approach. 690.cl2KO-GFP or 690.cl2KO-GFP-Cdc42ep5 cells were injected subcuta-
neously in mice. Grown living tumors on anaesthetized mice were then exposed and imaged using two-photon microscopy. (I) Intravital imaging of 690.cl2KO-
GFP or 690.cl2KO-GFP-Cdc42ep5 tumors (green, melanoma cells; magenta, collagen fibers). Right panels show motion analysis images from different time
points where static cells appear white; arrows indicate fast-moving cells represented as a trail of blue-green-red pseudocolors. Scale bars, 50 µm. (J) Violin plot
showing individual speed of moving cells from I. n, moving cells in five mice per condition; Mann–Whitney test. KO, knockout.
Farrugia et al. Journal of Cell Biology 4 of 19
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migration, as it mediates the maturation of nascent focal
complexes to FAs (Burridge and Wittchen, 2013). This process
requires myosin-mediated tension as well as the formation and
maintenance of an F-actin network (Choi et al., 2008). The
protein Paxillin is recruited early into focal complexes and
plays a key scaffolding role at FAs. Its phosphorylation at Y31
and Y118 is crucial for FA formation (Petit and Thiery, 2000).
Our previous observations suggested that CDC42EP5 may be
part of the actomyosin machinery that drives the maturation of
focal complexes to FAs in melanoma. To test this in more detail,
we first investigated Cdc42ep5 association with FAs. Confocal
microscopy analyses showed that Cdc42ep5 was present at
actin fibers that connected with FAs but showed no clear lo-
calization at pY188-Paxillin areas (Fig. 3 D). Together, these
data indicated that Cdc42ep5 is not part of the FA but localizes
at high contractile F-actin filaments associated with FAs, sug-
gesting a potential role in FA maturation. To test this, FA for-
mation and dynamics in 690.cl2 cells were studied after
Cdc42ep5 silencing. Using pY118-Paxillin staining, we observed
that Cdc42ep5-depleted cells presented smaller and dot-like
adhesions that localized closer to the cell periphery compared
with control cells (Fig. 3 E), features that are characteristic of
Figure 2. CDC42EP5 modulates actomyosin func-
tion in melanoma in 3D. (A) Image of a 690.cl2 cell on
collagen-rich matrix expressing GFP-Cdc42ep5 (green)
and stained for F-actin (magenta) and pS19-MLC2
(cyan); collagen fibers (gray) were captured by reflec-
tance signal. Individual grayscale channels are also
shown. Scale bar, 10 µm. (B) Images of 690.cl2 cells on
collagen-rich matrices after transfection with control
(siCtr) or two individual Cdc42ep5 (siEp5) siRNAs. Im-
ages show staining for F-actin (magenta) and pS19-
MLC2 (green); collagen fibers (gray) were captured by
reflectance signal. Scale bars, 40 µm. (C) Violin plots
showing roundness index (left), F-actin mean intensity
(middle), and pS19-MLC2 mean intensity (right) of in-
dividual cells from B. n represents individual cells;
Kruskal–Wallis and Dunn’s tests: **, P < 0.01; ***, P <
0.001; #, P < 0.0001. (D) Western blots showing indi-
cated protein levels in 690.cl2 cells after transfection
with control (siCtr) and two individual Cdc42ep5 (siEp5)
siRNAs. Graphs show quantification of normalized pS19-
MLC2 and total MLC2 levels. Bars indicate mean ± SEM
(n = 6 [pMLC2] and 5 [MLC2] independent experiments;
one-way paired ANOVA, Dunnett’s test: †, not signifi-
cant; ***, P < 0.001; #, P < 0.0001). (E) Images and
graph showing gel contraction of 690.cl2 cells after in-
dicated treatments. Bars indicate mean ± SEM (n = 3
independent experiments; one-way paired ANOVA,
Dunnett’s test: **, P < 0.01). (F) Graph shows expres-
sion of CDC42EP5 mRNA normalized to GAPDH expres-
sion in human melanoma cell lines with increasing
rounding coefficients. Pearson’s correlation coefficient
(r), statistical significance (p), and linear regression (red
line) are shown. Each point in the graph represents the
mean value of three independent experiments.
Farrugia et al. Journal of Cell Biology 5 of 19
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Figure 3. Cdc42ep5 promotes stress fiber formation and FA maturation in 2D. (A) Image shows a 690.cl2 cell expressing GFP-Cdc42ep5 (green) on glass
and stained for F-actin (magenta) and DAPI (blue). Additional panels show magnifications of perinuclear and peripheral areas. Scale bars, 12.5 µm. (B) Graph
shows Pearson’s correlation coefficient of GFP-Cdc42ep5 signal against perinuclear and peripheral F-actin staining and tubulin staining. Bars indicate mean ± SEM
Farrugia et al. Journal of Cell Biology 6 of 19
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immature focal complexes (Petit and Thiery, 2000). Zyxin is a
FA protein that distinguishes mature FA from focal complexes,
as it is recruited later into the complex (Petit and Thiery,
2000). Knockdown of Cdc42ep5 in 690.cl2 cells resulted in a
complete loss of Zyxin-positive adhesions (Fig. S3 D). Impor-
tantly, this defect was observed when cells were cultured both
on glass and on fibronectin, ruling out any potential effect asso-
ciated with defective cell adhesion. Furthermore, time-lapse
imaging of Paxillin-GFP showed that Cdc42ep5 knockdown af-
fected the elongation of FAs, which appeared static over time
(Video 4 and Fig. 3 F). As a result of deficient FA maturation,
Cdc42ep5-depleted cells failed to activate FA downstream sig-
naling (i.e., Src; Calvo et al., 2015; Fig. 3 G) and presented defects
in single-cell migration in 2D (Fig. S3 E). Interestingly, it was
observed that Cdc42ep5 was the main Borg protein involved in
the process. While silencing Cdc42ep1 and Cdc42ep3 marginally
reduced pY418-Src levels, knocking down Cdc42ep5 resulted in
significant inhibition of Src activity (Fig. S3 F). Together, these
data indicated that in 2D melanoma cells CDC42EP5 forms fila-
mentous structures that overlap actin filaments and promotes the
formation of perinuclear actomyosin fibers, leading to the mat-
uration of FAs and increased cell motility.
SEPT9 promotes actomyosin activity, invasion, and metastasis
in melanoma
Borg proteins, including CDC42EP5, have been shown to pri-
marily promote septin filament assembly (Calvo et al., 2015;
Joberty et al., 2001). In humans, septins are encoded by 13 dif-
ferent genes that encode multiple septin isoforms (Mostowy and
Cossart, 2012). Septins can associate with distinct actin net-
works, modulate their formation, and facilitate myosin activa-
tion (Spiliotis, 2018). In amoeboid T lymphocytes, it has been
proposed that septins tune actomyosin forces during motility
(Gilden et al., 2012). To assess whether CDC42EP5 was func-
tioning via septins to regulate actomyosin function and invasion
in melanoma, we first analyzed whether there was any partic-
ular septin associated with melanoma aggressiveness. Analyses
of datasets of human material (Riker et al., 2008; Talantov et al.,
2005) indicated that SEPT9 was the only septin gene whose up-
regulation is associated with melanoma progression and dis-
semination (Fig. 4 A; and Fig. S4, A and B). These results pointed
to a specific role of SEPT9 in melanoma invasion and metastasis
that we sought to investigate further.
SEPT9 is the only member of the septin family that directly
promotes actin polymerization and cross-linking (Dolat et al.,
2014; Smith et al., 2015). However, other septins such as
SEPT2 and SEPT7 have been shown to colocalize with actin fi-
bers and modulate their formation in nonmalignant cells such as
fibroblasts (Calvo et al., 2015), lymphocytes (Gilden et al., 2012)
and endothelial cells (Liu et al., 2014), as well as breast cancer
cells (Zhang et al., 2016). To assess SEPT9 relevance in mela-
noma in comparison to other critical septins (i.e., SEPT2 and
SEPT7), we proceeded to analyze the effect of perturbing Sept2,
Sept7, and Sept9 function in 690.cl2 cells by specifically tar-
geting their expression by RNAi. All individual treatments
specifically decreased the expression of their targeted septin,
although there was a slight reduction in Sept9 expression after
depletion of Sept7 (Figs. 4 B and S4 C). Only disruption of Sept9
expression affected both cell roundness and the generation of an
actomyosin cortex (as read by pS19-MLC2 and F-actin levels) in
690.cl2 cells seeded on collagen-rich matrices (Fig. 4, C and D;
and Fig. S4 D). Similar findings were observed after SEPT9 de-
pletion in human melanomaWM266.4 cells (Fig. S4 E). Analyses
of cells in 2D culture showed that only depletion of Sept9 and, to
a lesser extent, Sept7 affected the generation of perinuclear
F-actin fibers (Fig. 4 E). Similar to Cdc42ep5 depletion, silencing
Sept9 led to a marked reduction in FA size (Fig. 4 E). Sept2-
depleted cells also exhibited smaller FAs. In support of a spe-
cific role of Sept9 in controlling actomyosin contractility in
melanoma, we observed that Sept9 silencing significantly re-
duced the ability of parental 690.cl2 cells to migrate in transwell
assays (Fig. 4 F). There was no significant change in the mi-
gration ability after Sept2 or Sept7 knockdown. In 3D collagen
invasion assays, knockdown of Sept9 resulted in a significant
decrease in invasion (Fig. 4 G). On the other hand, Sept2 de-
pletion did not affect invasion whereas silencing Sept7 surpris-
ingly increased the invasive potential of 690.cl2 cells. Importantly,
these phenotypic and functional defects were associated with a
reduced ability of 690.cl2 cells to metastasize in tail-vein as-
says after Sept9 depletion (Fig. 4 H). Altogether, these data
point to SEPT9 as the key regulator of the actomyosin cyto-
skeleton during melanoma local invasion and distant meta-
static colonization.
CDC42EP5 promotes SEPT9 actin cross-linking, leading to
enhanced actomyosin activity
Having established a specific role for SEPT9 in regulating acto-
myosin contractility and invasion in melanoma, we next sought
to investigate whether CDC42EP5 was modulating SEPT9 func-
tion in these processes. 690cl2 cells in 2D cultures presented
(n = 10 independent cells [perinuclear and peripheral F-actin] and 5 [tubulin]; one-way paired ANOVA, Dunnett’s test: *, P < 0.05; ***, P < 0.001; #, P <
0.0001). (C) Images of 690.cl2 cells after transfection with control (siCtr) and two individual Cdc42ep5 (siEp5) siRNAs on glass. Images show F-actin (magenta)
and DAPI (blue) staining with zoom-up panels showing perinuclear and peripheral regions. Scale bars, 12.5 µm. Graph is a violin-plot quantification of F-actin
intensity in the perinuclear and peripheral regions in the indicated points. n, specific regions in individual cells; Kruskal–Wallis and Dunn’s tests: *, P < 0.05; #, P <
0.0001. (D) Images show individual and merged channels of 690.cl2 cells expressing GFP-Cdc42ep5 (green) on glass and stained for F-actin (magenta) and
pY118-Paxillin (blue). Scale bar, 5 µm. Graph at the bottom is a violin plot showing the Pearson’s correlation coefficient of Cdc42ep5 and F-actin staining against
pY118-Paxillin–positive areas. (n, pY118-Paxillin–positive areas in individual cells; unpaired t test.) (E) Images of 690.cl2 cells on glass. Images show F-actin
(magenta), pY118-Paxillin (green), and DAPI (blue) staining. Single-channel magnification of pY118-Paxillin staining is also shown. Scale bars, 25 µm. Graph is a
violin plot showing quantification of FA size (i.e., pY118-Paxillin–positive area). n, peripheral regions in individual cells; Kruskal–Wallis and Dunn’s: #, P < 0.0001.
(F) Images show motion analysis of Paxillin-GFP after TIRF imaging. Scale bars, 25 µm. (G)Western blots showing indicated protein levels in 690.cl2 cells after
transfection with control (siCtr) and two individual Cdc42ep5 (siEp5) siRNAs. Right graphs show quantification of normalized p418-Src levels. Bars indicate mean
± SEM (n = 5 independent experiments; one-way paired ANOVA, Dunnett’s test: *, P < 0.05; ***, P < 0.001).
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Figure 4. SEPT9 is required for actomyosin contractility and invasion inmelanoma. (A) Violin plots show SEPT9 expression in human tissues from normal
(Norm) skin, nevus, and melanoma (left: Talantov et al. dataset, GSE3189) and primary melanoma and metastatic melanoma (right: Riker et al. dataset,
GSE7553). n, individual patients; Kruskal–Wallis and Dunn’s tests [Talantov] and Mann–Whitney test [Riker]: †, not significant; #, P < 0.0001. (B)Western blots
showing indicated protein levels in 690.cl2 cells after transfection with control (siCtr) and Sept2, Sept7, and Sept9 siRNA. (C) Images show F-actin and pS19-
MLC2 staining of parental 690.cl2 after transfection with control (siCtr), Sept2, Sept7, and Sept9 siRNA on collagen-rich matrices. Scale bars, 75 µm. (D) Violin
Farrugia et al. Journal of Cell Biology 8 of 19




 http://rupress.org/jcb/article-pdf/219/9/e201912159/1048538/jcb_201912159.pdf by guest on 20 August 2020
Cdc42ep5 colocalized with Sept9 filaments (Fig. 5 A). These fil-
aments exhibited a clear overlap with F-actin stress fibers in the
perinuclear region, but not in the cell periphery. Similarly,
Sept9 was also observed in the actin cortex with Cdc42ep5 and
F-actin in amoeboid 690.cl2 cells seeded on collagen-rich 3D
matrices (Fig. 5 B). Importantly, modulating Cdc42ep5 expres-
sion amply affected the formation of Sept9 structures. Thus, we
observed that silencing Cdc42ep5 reduced the formation of
perinuclear Sept9 filaments and increased its cytosolic pool in
2D culture (Fig. 5 C). In 3D environments, Sept9 presented a
sparse cytosolic pattern in 690.cl2KO-GFP, whereas stable re-
constitution of Cdc42ep5 expression redistributed Sept9 to
cortical regions cells (Fig. 5 D).
As opposed to other septins, SEPT9 is the only known septin
that binds actin filaments directly and can promote the cross-
linking of prepolymerized actin filaments, even at suboptimal
concentrations (Dolat et al., 2014; Smith et al., 2015; Fig. S5 A).
Using low-speed actin sedimentation assays, we confirmed that
neither Cdc42ep5 nor SEPT6/7 induced F-actin cross-linking on
their own (Fig. S5 B). Interestingly, we observed that addition of
recombinant Cdc42ep5 increased the amount of cross-linked
F-actin induced by SEPT9 (Fig. 5 E). In addition, using F-actin
polymerization assays and F-actin–binding assays, we con-
firmed previous findings describing the ability of recombinant
SEPT9 to bind F-actin and promote actin polymerization (Dolat
et al., 2014; Smith et al., 2015; Fig. S5, C and D); on the other
hand, Cdc42EP5 exhibited no actin polymerization activities and
a minimal interaction with F-actin.
SEPT9 is a crucial effector of CDC42EP5 function in melanoma
These data suggested that CDC42EP5 acted primarily by re-
inforcing the ability of SEPT9 to cross-link actin filaments into
stress fibers and cortical actin, which is required for actomyosin
contractility in 2D and 3D settings, respectively. To further
validate this idea, we generated a Cdc42ep5 mutant defective in
interaction with Sept2/6/7 by mutating key residues in the BD3
domain of Cdc42ep5 (Cdc42ep5GPS-AAA mutant; Fig. 6 A; Calvo
et al., 2015; Joberty et al., 2001). We confirmed that Cdc42ep5
was also able to interact with Sept9 and that this interaction
depended on an intact BD3 domain (Fig. S6 A).We assessed the
activity of this mutant in comparison to wild-type Cdc42ep5
(Cdc42ep5WT) by gain-of-function analyses in 690.cl2KO cells
(Fig. S6 B). Contrary to Cdc42ep5WT reconstitution, expres-
sion of Cdc42ep5GPS-AAA in 690.cl2KO cells in 2D did not induce
the formation of perinuclear Sept9 networks (Fig. S6 C), actin
stress fibers or matured FAs (Fig. 6 B). In 3D, expression of
Cdc42ep5GPS-AAA in 690.cl2KO cells did not affect cell rounding
and pS19-MLC2 levels, whereas Cdc42ep5WT significantly in-
creased these parameters (Fig. 6 C; Fig. S6, D and E). Impor-
tantly, these phenotypes were concomitant with functional
defects, as septin binding was absolutely required for Cdc42ep5-
dependent transwell migration and collagen invasion (Fig. 6, D
and E). Overall, these results confirm that Cdc42ep5 requires
Sept9 interactions to promote actomyosin-dependent proinva-
sive behaviors in melanoma.
To further confirm that SEPT9 was a crucial effector of
CDC42EP5 function in melanoma, we next investigated whether
elevating Sept9 activity was sufficient to rescue the functional
defects associated with loss of Cdc42ep5. For this, we used a
SEPT9 isoform containing the N-terminal domain (SEPT9_V1),
which has been shown to present enhanced activities (Gonzalez
et al., 2007). Thus, reconstituting SEPT9 activity in 690.cl2KO
cells by ectopic expression of SEPT9_V1 was able to induce cell
rounding and actomyosin activity in 3D culture (Figs. 6 F and
S6 F). In addition, SEPT9_V1 expression reconstituted perinu-
clear actin fiber and FA formation in 690.cl2KO cells (Fig. 6 G)
and increased their migratory capabilities to levels similar to
those obtained by Cdc42ep5 expression (Fig. 6 H). Overall these
results illustrate a unique role for Sept9 in controlling actomy-
osin structure and function in melanoma and place it as the key
effector of CDC42EP5 functions in regulating migration, inva-
sion, and metastasis.
Discussion
Here, we identify CDC42EP5 as a new regulator of melanoma
invasion and metastasis. We demonstrate that CDC42EP5 forms
filamentous structures that associate with F-actin and promotes
the assembly of higher-order actomyosin bundles in 2D and 3D.
Contrary to other actin bundling regulators such as Fascin,
α-Actinin, and Filamin (Stevenson et al., 2012), CDC42EP5 pro-
motes actin bundling not directly but by controlling septin
network reorganization. Thus, a septin-binding defective mu-
tant is not able to affect actin structures or confer migratory and
invasive capabilities in melanoma.
Septins such as SEPT2, SEPT4, SEPT6, SEPT7, and SEPT9
have been shown to colocalize with actin most prominently in
stress fibers, and their perturbation can alter actin organization
(Spiliotis, 2018). In particular, SEPT7 is proposed to be the es-
sential septin in the formation of septin oligomers and fila-
mentous structures (Zent et al., 2011). In addition, SEPT2 binds
myosin II directly and this interaction is proposed to promote
plots showing roundness index (top), F-actin mean intensity (center), and pS19-MLC2 mean intensity (bottom) of individual cells from C. n, individual cells;
Kruskal–Wallis and Dunn’s tests: †, not significant; ***, P < 0.001; #, P < 0.0001. (E) Images show F-actin (magenta), pY118-Paxillin (green), and DAPI (cyan)
staining in 690.cl2 cells after transfection with indicated siRNAs on glass. Right panels show indicated magnifications of F-actin staining in the perinuclear and
peripheral regions, and pY118-Paxillin staining at the cell border. Scale bars, 12.5 µm. Violin plots show quantification of F-actin intensity in the perinuclear
(top) and peripheral (center) regions, and quantification of FA size (bottom). n, single regions from individual cells [top and center] and individual FAs [bottom];
Kruskal–Wallis and Dunn’s tests: †, not significant; ***, P < 0.001; #, P < 0.0001. (F and G) Graphs show fold migration ability (F) and fold invasion into collagen
(G) of 690.cl2 cells after transfection with indicated siRNAs. Bars indicate mean ± SEM (n = 3 [F] and 4 [G] independent experiments; paired t tests: †, not
significant; *, P < 0.05; **, P < 0.01). (H) Images of mouse lungs at 2 and 24 h after tail injection with 690.cl2 cells transfected with control (siCtr-Red) or Sept9
(siSept9-Green) siRNA. Scale bars, 100 µm. Graph shows proportions (%) of siCtr and siSept9 cells within the lungs at 24 h. Lines represent mean ± SEM (n = 5
mice; unpaired t test). AU, arbitrary units.
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Figure 5. CDC42EP5 associates with SEPT9 and F-actin to promote F-actin cross-linking and the generation of actomyosin structures. (A) Left panel
shows a 690.cl2 cell expressing GFP-Cdc42ep5 (green) and stained for Sept9 (blue) and F-actin (magenta). Scale bars, 10 µm. Middle panels show merged and
individual channel magnifications of indicated areas: a, perinuclear; b and c, peripheral. Graph shows Pearson’s correlation coefficient of Cdc42ep5, Sept9, and
F-actin in perinuclear and peripheral areas. Bars indicate mean ± SEM (n = 7, 6, and 12 independent regions in individual cells; unpaired t tests: †, not significant;
Farrugia et al. Journal of Cell Biology 10 of 19
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actin–septin filament association and enhance MLC2 activation
(Joo et al., 2007). In amoeboid lymphocytes, SEPT7 has been
shown to modulate the actomyosin cytoskeleton in cortical
contraction (Gilden et al., 2012). SEPT9 occupies the terminal
position in septin oligomers and has been proposed to be es-
sential for filament formation, although perturbation of SEPT9
function only results in late abscission defects during cytoki-
nesis but does not affect septin-dependent steps earlier in mi-
tosis (Kim et al., 2011). On the contrary, SEPT2, SEPT7, and
SEPT11 are required at the early stages of cytokinesis (Estey
et al., 2010). Our orthogonal analyses of differential gene ex-
pression in clinical samples coupled to loss-of-function charac-
terization indicate that SEPT9 is the main septin effector of
CDC42EP5, which was further confirmed using in vitro analyses
and epistatic approaches. In the context of melanoma, SEPT9 is
essential for the generation of an actomyosin cortex in 3D and
stress fibers in 2D. Altogether, it appears that SEPT9 functions in
actomyosin networks independently of the formation of ca-
nonical SEPT2/6/7/9 oligomers. This specific role appears to be
critical in the stabilization of highly contractile actomyosin
structures such as the cleavage furrow (Estey et al., 2010), stress
fibers (Dolat et al., 2014; Fig. 4), and actomyosin cortex (Fig. 4)
and may be related to the unique ability of SEPT9 to cross-link
F-actin that is not shared by the rest of septins (Dolat et al., 2014;
Smith et al., 2015). In agreement, we demonstrate mechanisti-
cally that CDC42EP5 interacts with SEPT9 and potentiates its
F-actin bundling activity required for the stabilization of acto-
myosin networks.
Actomyosin networks such as the actomyosin cortex in 3D
and stress fibers in 2D are critical structures for exerting and
resisting mechanical tension. In addition to the myosin motors
required for generating force, these structures require addi-
tional levels of F-actin cross-linking to generate bundles capable
of resisting the mechanical loads applied to them. Myosin II is
the main actin-based contractile myosin motor that cross-links
actin filaments at the cell cortex and stress fibers and regulates
cellular tension (Stevenson et al., 2012; Vicente-Manzanares
et al., 2009). Accordingly, actomyosin activity in melanoma
has primarily been shown to be exerted via Rho-ROCK modu-
lation of myosin activity (Herraiz et al., 2015; Pandya et al., 2017;
Sanz-Moreno et al., 2008, 2011; Sanz-Moreno and Marshall,
2010) and is critical in modulating fast amoeboid invasion and
metastasis (Sanz-Moreno et al., 2008; Sanz-Moreno and Mar-
shall, 2010). We demonstrate that actomyosin function in mel-
anoma is also dependent on the additional support provided by
SEPT9 in those structures, which is modulated by the septin
regulator CDC42EP5. Thus, we observe both CDC42EP5 and
SEPT9 colocalizing with actomyosin networks in 2D and 3D, and
their silencing is associated with the destabilization of F-actin
structures and reduced actomyosin function. Thus, CDC42EP5:
SEPT9 filaments appear to complement myosin II function and
mechanically stabilize these structures. This new regulatory axis
of actomyosin function in melanoma is required for invasion
and metastasis.
Septins are increasingly associated with cytoskeletal reg-
ulation and cell migration, and potential roles in modulating
cancer aggressiveness are emerging (Angelis and Spiliotis,
2016; Spiliotis, 2018). Determining their relevance in different
cancers and understanding how they are regulated is therefore
critical. We show a specific SEPT9 up-regulation in human
melanoma and particularly in metastatic melanoma, which may
underpin its functional relevance in this setting. In addition, we
show that melanoma cells present characteristic SEPT9 net-
works that modulate their migratory behavior by potentiating
actomyosin activity. In addition, we identify a new regulatory
mechanism of septin function in cancer. Thus, CDC42EP5 is re-
quired for the assembly of SEPT9 structures at actomyosin
bundles in 2D and 3D, possibly by enabling its correct positioning
within the cell or within actin filaments. Thus, silencing of
Cdc42ep5 in melanoma cells seeded in 2D leads to the disas-
sembly of higher-order Sept9 filaments, whereas in 3D results in
reduced cortical Sept9 (Fig. 7).
Melanoma cells can switch between mesenchymal and
amoeboid modes of migration, and this plasticity is a critical
factor in the difficulties encountered in the clinic to target me-
tastasis (Gandalovičová et al., 2017). Since actomyosin is re-
quired for both migratory modes, our results suggest that the
CDC42EP5–SEPT9 axis could potentially reduce both rounded-
amoeboid and elongated-mesenchymal modes of invasion. Thus,
cells lacking CDC42EP5 or SEPT9 present defects in stress fiber
formation and FA maturation that are generally required for
mesenchymal migration. In agreement, silencing Cdc42ep5 re-
sulted in a significant decrease in directed migration and mo-
tility in 2D, which favors elongated-mesenchymal behaviors. We
also describe that CDC42EP5 is required for migration and in-
vasion in a mesenchymal model of breast cancer such as MDA-
MB-231-LM2. In breast cancer, SEPT9 has been reported to
promote invasion by enhancing ECM degradation through
metalloproteinase secretion (Marcus et al., 2019), a hallmark
of mesenchymal migratory behaviors. Similar results were
*, P < 0.05; #, P < 0.0001). (B) Image of 690.cl2 cell expressing GFP-Cdc42ep5 (green) on collagen-richmatrices. Staining of F-actin (magenta) and Sept9 (cyan)
and individual channel magnifications of indicated area are also shown. Scale bars, 10 µm. (C) Images show F-actin (magenta), Sept9 (green), and DAPI (blue)
staining in 690.cl2 cells on glass after transfection with indicated siRNAs. Magnifications of perinuclear areas are shown. Scale bars, 20 µm. Violin plot shows
quantifications of cytosolic and perinuclear intensity of Sept9 staining. n, individual cells; Mann–Whitney’s test: †, not significant; ***, P < 0.001; #, P < 0.0001.
(D) Images show F-actin (magenta), GFP (green), and Sept9 (cyan) of 690.cl2KO cells expressing GFP or GFP-Cdc42ep5 on collagen-richmatrices. Scale bars, 2.5
µm. Single channels for GFP and Sept9 signals are shown. Panels on the right showmagnifications of Sept9 signals in cortical and cytosolic areas. Violin plot at
the bottom shows quantification of cortical Sept9 signal. n, independent regions in individual cells; Mann–Whitney’s test. (E) Top panel is a Coomassie-stained
gel showing equal volumes of supernatant (S) and pellet (P) fractions from low-speed sedimentation of prepolymerized actin filaments in the presence of
recombinant Cdc42ep5 (1 µM), SEPT9 (1 µM), and both Cdc42eep5 (1 µM) and SEPT9 (1 µM). Bottom panel shows an anti-actin Western blot of the same
experiment. Graph shows the actin bundling coefficient (ratio of actin in pellet vs. supernatant) in the indicated experimental points. Bars indicate mean ± SEM
(n = 3 experiments; one-way ANOVA, Tukey’s test: †, not significant; *, P < 0.05; ***, P < 0.001). AU, arbitrary units.
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Figure 6. SEPT9 is a crucial effector of CDC42EP5 function in melanoma. (A) Diagram showing the different domains in Cdc42ep5. Underneath are the
amino acid sequences of the BD3 segment in wild-type and septin-binding–defective mutant (GPS-AAA). (B) Images show GFP (green), F-actin (magenta),
Farrugia et al. Journal of Cell Biology 12 of 19
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obtained in a model of renal epithelial-mesenchymal transition,
where SEPT9 was required for mesenchymal migration (Dolat
et al., 2014). Together, these findings suggest that the CDC42EP5–
SEPT9 axis may be an interesting node to target melanoma
metastasis, as it might affect both modes of migration and cir-
cumvent the problem of melanoma cell plasticity (Sanz-Moreno
and Marshall, 2010).
Although the link between Borg proteins and cytoskeletal
rearrangements is longstanding (Joberty et al., 1999), very little
is known regarding their relevance in cancer and invasion.
Here, we have performed for the first time a comparative study
of the ability of different Borg proteins to regulate cancer cell
migration. Our analyses identify a unique role for CDC42EP5 in
conferring promigratory and proinvasive properties that is not
consistently shared by other members of the family. This is
surprising, as all Borg proteins share both regulatory and
effector domains (Farrugia and Calvo, 2016). We can specu-
late that specificity in this case is achieved via transcriptional
regulation of these genes. Thus, we show a specific up-regulation
of CDC42EP5 in rounded-amoeboid melanoma cells and describe
a concomitant function of CDC42EP5 in modulating actomyosin
activity in melanoma. This may explain its unique requirement
for migration in confined environments such as collagen inva-
sion assays or in vivo migration, as these processes rely signif-
icantly in actomyosin function. On the other hand, other Borg
proteins may participate in modes of migration that require
different cytoskeletal rearrangements. For example, CDC42EP4
function on normal mammary epithelia 2D migration was as-
sociated to enhanced filopodia formation (Zhao and Rotenberg,
2014). Still to be determined are the molecular features confer-
ring this unique role to CDC42EP5. This may result from unique
binding partners, structural characteristics, or additional regu-
lations that dictate its specific localization and/or function.
Materials and methods
Cell lines
Murinemelanoma 690.cl2 cells (a kind gift from RichardMarais,
Cancer Research UK Manchester Institute, Manchester, UK)
were generated from spontaneous melanoma lesions from
BrafV600E murine models (Dhomen et al., 2009; Kümper et al.,
2016). WM266.4 humanmelanoma cells (a gift from Chris Bakal,
The Institute of Cancer Research, London, UK) harbor a BrafV600D
mutation and were isolated from a metastatic lesion (skin) of
a female patient who presented with malignant melanoma.
MDA-MB-231-LM2 (a gift from Chris Bakal, The Institute of
Cancer Research) is a derivative of triple-negative breast can-
cer cell model MDA-MB-231 that was selected for its ability to
metastasize to lung tissue in vivo. Mouse embryonic fibroblasts
were a kind gift from AfshanMcCarthy (The Institute of Cancer
Research, London, UK) and were kept at low passage while
avoiding confluency. All of these cell lines were cultured in
DMEM (Sigma), GlutaMax (Gibco), and 10% FBS and incubated
at 37°C in 5% CO2. A375P and A375M2 melanoma cells were
from Richard Hynes (Massachusetts Institute of Technology,
Cambridge, MA). CHL, SKMEL28, 501MEL, SKMEL2, SKMEL23,
SBCL2, WM1361, WM1366, and WM3670 melanoma cells were
pY118-Paxillin (cyan), and DAPI (gray) in 690.cl2KO cells expressing GFP, GFP-Cdc42EP5WT, or GFP-Cdc42EP5GPS-AAA on glass. Single-channel magnifications of
indicated areas are shown. Scale bars, 10 µm. Violin plots show quantification of perinuclear F-actin intensity (top) and FA size (bottom). n, independent
regions in individual cells; one-way ANOVA Tukey’s test: †, not significant; *, P < 0.05; *, P < 0.05; #, P < 0.0001. (C) Images show GFP, F-actin and pS19-MLC2
in 690.cl2KO cells expressing GFP, GFP-Cdc42EP5WT, or GFP-Cdc42EP5GPS-AAA on collagen-rich matrices. Scale bar, 75 µm. Bottom graphs show violin plots for
roundness index (left) and pS19-MLC2 mean intensity (right) of individual cells. n, individual cells; Kruskal–Wallis and Dunn’s tests: †, not significant; #, P <
0.0001. (D and E) Graphs show fold migration ability (D) and 3D collagen invasion (E) of 690.cl2KO cells expressing GFP, GFP-Cdc42EP5WT, or GFP-
Cdc42EP5GPS-AAA. Bars indicate mean ± SEM (n = 3 [D] and 6 [E]; one-way ANOVA Tukey’s test: †, not significant; *, P < 0.05; **, P < 0.01; #, P <
0.0001). (F) Images show F-actin (magenta), GFP (green), and pS19-MLC2 (cyan) in 690.cl2KO cells expressing GFP or GFP-SEPT9_V1 on collagen-rich matrices.
Individual channels are also shown. Scale bars, 75 µm. Violin plots show roundness index (left) and pS19-MLC2 mean intensity (right) of individual cells. n,
individual cells; Mann–Whitney test. (G) Images showing GFP (green), F-actin (magenta), and pY118-Paxilin (cyan) in 690.cl2KO cells expressing GFP or GFP-
SEPT9_V1 on glass. Right panels show indicated magnifications. Scale bars, 10 µm. Violin plots show quantification of F-actin intensity in the perinuclear region
(left) and of FA size (right). n, single regions from individual cells (left) and individual FAs (right); Mann–Whitney test. (H) Graph shows fold migration ability of
690.cl2KO cells expressing GFP, GFP-SEPT9_V1, or GFP-Cdc42ep5WT. Bars indicate mean ± SEM (n = 3 experiments; paired t test: *, P < 0.05). AU, arbitrary
units. KO, knockout.
Figure 7. CDC42EP5 is required for melanomamigration and invasion by
promoting actomyosin contractility via SEPT9. Diagram summarizing the
main findings of this study.
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from RichardMarais (Cancer Research UKManchester Institute,
Manchester, UK). Cells were maintained in DMEM (RPMI for
WM1361, SBCL2, and WM3670) containing 10% FBS and kept in
culture for a maximum of three or four passages. All cell lines
tested negative for mycoplasma infection with MycoAlert
(Lonza).
cDNA, RNAi, and reagents
Murine pEGFP-Cdc42ep5 (N-terminal GFP) was a kind gift from
Facundo Batista and Shweta Aggarwal (Francis Crick Institute,
London, UK). This plasmid was used as a template to generate
GFP-tagged mutant versions Cdc42ep5GPS-AAA using In-Fusion
cloning (Takara). To allow for lentiviral infection and stable
expression, these cDNAs were all then subcloned into a pCSII-
IRES-blasti vector backbone at NheI and BamHI restriction sites.
The wild-type version of Cdc42ep5 was also subcloned in-frame
into pGEX backbone (pGEX-GST-Cdc42ep5) for generation of
recombinant protein. Details of cloning strategy are available
upon request. GFP-SEPT9_V1 plasmid was a kind gift from
Cristina Montagna (Albert Einstein College of Medicine, Bronx,
NY). Paxillin-GFPwas a kind gift from Chris Bakal (The Institute
of Cancer Research, London, UK). pCSII-IRES2-blasti-GFP and
pCSII-IRES2-blasti-mCherry were a kind gift from Erik Sahai
(Francis Crick Institute, London, UK). pnCS-Strep-SEPT6/7 is
a bicistronic, spectinomycin-resistant plasmid that expresses
human SEPT6 and strep-SEPT7 in tandem; pET28-SEPT9
encodes a kanamycin-resistant His-tagged version of human
SEPT9 (Mavrakis et al., 2016). Both plasmids were a kind gift
from Elias Spiliotis (Drexel University, Philadelphia, PA).
siRNAs were purchased from Dharmacon and are listed in
Table S1.
Generation of CRISPR knockout cell lines
The CRISPR plasmid U6gRNA-Cas9-2A-GFP containing a guide
RNA targeting murine Cdc42ep5 was purchased from Sigma
(MM0000377239). Parental 690.cl2 cells were transfected with
that plasmid using Lipofectamine (Life Technologies) following
the manufacturer’s instructions, and GFP-positive cells were
single sorted into 96-well plates after 24 h. Individual cell clones
were expanded and the Cdc42ep5 locus targeted by CRISPR was
sequenced and subjected to Western blot analysis for knockout
validation (690.cl2KO). Cdc42ep5-null clones were infected with
GFP-Cdc42ep5–expressing lentivirus to generate 690.cl2KO cells
reexpressing wild-type Cdc42ep5 (690.cl2KO-GFP-Cdc42ep5) or
the septin-binding–defective mutant of Cdc42ep5 (690.cl2KO-
GFP-Cdc42ep5GPS-AAA). Alternatively 690.cl2KO cells were
infected with plain GFP-expressing lentivirus to generate
690.cl2KO-GFP cells.
Transfections
Cells were seeded at 75% confluency and transfected using
RnaiMax (Life Technologies) for siRNA (100 nM final concen-
tration) and Lipofectamine 3000 (Life Technologies) for plas-
mids following the manufacturer’s instructions. Cell lines stably
expressing cDNA (GFP-Cdc42ep5 or GFP/mCherry) were gen-
erated by lentiviral infection followed by blasticidin selection for
2 wk (4 µg ml−1). Alternatively, fluorescent-labeled cells were
sorted by FACS. For the generation of the nonvirally transduced
stable 690.cl2 cells expressing GFP, GFP-Paxillin, or GFP-
SEPT9_V1, parental cells were transfected with the relevant
plasmids using Lipofectamine 3000 following the manu-
facturer’s instructions. Next, 48 h after transfection, 400 µgml−1
G418 (Sigma) was added as a selection agent to remove non-
transfected cells. Cells were probed for the expression of plas-
mids based on GFP expression and kept at low passage.
Proliferation assay
Cells were seeded in a 96-well in triplicate at 5,000 cells per well
and grown in normal culture conditions. AlamarBlue (Thermo-
Fisher) assay was used according to manufacturer’s instructions
to compare cell growth and viability at the indicated time points.
Samples were run in quadruplicate and averaged. Values were
normalized to values at day 0.
Transwell migration
5 × 104 cells were suspended in serum-free media and seeded
onto transwell inserts with 8-µm pores (Corning) on a reservoir
containing 10% FBS and 10 ng ml−1 TFGβ (Peprotech). After 48 h,
the cells on the lower chamber were fixed in 4% PFA for 15 min,
stained with DAPI and imaged using a confocal multiphoton
inverted microscope with a motorized XY scanning stage and
four nondescanned detectors (twoHybrid Detectors [HyD] + two
photomultiplier tubes [PMT]; Leica TCS SP8). A tile scan con-
taining the entire well was acquired with a 10×/0.4 NA objective
lens using LASX software (Leica). The number of cells (i.e., nuclei)
was quantified using ImageJ. Data are expressed as mean ± SEM
(normalized to control cells).
3D inverted invasion assay
For 690.cl2, cells were suspended in 2.3 mg ml−1 rat tail collagen
at 105 cells ml−1. 100-µl aliquots were dispensed into 96-well flat
bottom plates (Corning) precoated with 0.2% fatty acid–free BSA
(Sigma). Cells were spun to the bottom of the well by centrifu-
gation at 300 ×g for 5 min at 4°C and incubated at 37°C in 5% CO2
for 1 h. Once collagen had polymerized, DMEM with 10% FBS
and TGF-β (10 ng ml−1) was added on top of the collagen. After
24-h incubation at 37°C in 5% CO2, cells were fixed and stained
for 4 h in 16% PFA solution containing 5 µg ml−1 Hoechst 33258
nuclear stain (Invitrogen). The plates were then imaged using an
Operetta High Content Imaging System (HH12000000; Perkin-
Elmer) and Harmony software (PerkinElmer) at z-planes 0, 30,
and 60 µm. The number of cells at each plane (i.e., nuclei) was
quantified using the Harmony software package (PerkinElmer).
The invasion index was calculated as the sum of the number of
cells at 60 µm divided by the total number of cells (at 0, 30, and
60 µm). The invasion index of each condition was then nor-
malized to the respective control. Samples were run in triplicate
and averaged. Data are expressed as mean ± SEM (normalized to
control cells). Alternatively, cells were stained with phalloidin-
tetramethylrhodamine (TRITC) to generate 3D reconstructions
of collagen invasion assays. Z-stacks (1 µm size) were acquired
from bottom to top using a Leica TCS SP8 confocal microscope
with 20x/0.75 NA objective lens, and 3D reconstructions gen-
erated using LAS X software (Leica).
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For WM266.4 and MDA-MB-231-LM2 cells: 100 µl of diluted
1:1 (Matrigel/PBS) mix was pipetted into transwell inserts in a
24-well tissue culture plate and left to set for 30 min at 37°C.
When the Matrigel had set, the transwell inserts were inverted
and 5 × 104 cells in normal media were pipetted onto the filter.
The transwell inserts were then carefully covered with the base
of the 24-well tissue culture plate, making contact with each cell
suspension droplet, and the plate incubated in the inverted state
for 4 h to allow cell attachment. After this, plates were turned
upside up, and each transwell insert was washed three times
with 1 ml serum-free DMEM and finally placed in a well con-
taining serum-free DMEM. Full normal media (10% FBS) was
gently pipetted on top of the set Matrigel/PBS mixture and in-
cubated for 5 d at 37°C in 5% CO2. After this, transwell inserts
were fixed in 4% PFA, stained with DAPI and phalloidin-TRITC,
and imaged by confocal microscopy (TCS SP8; Leica) with 20×/
0.75 NA objective lens. Optical Z-sections were scanned at 15-µm
intervals moving up from the underside of the filter into the
Matrigel. The invasion index was calculated as the sum of the
area of cells at 30 µm divided by the total number of cells (at 0,
15, and 30 µm). Data are expressed as mean ± SEM (normalized
to control cells).
ECM-remodeling assay
To assess force-mediated matrix remodeling, 3 × 105 cells were
embedded in 120 µl of a 2.3 mg ml−1 rat tail collagen-1 gel in 24-
well glass-bottom MatTek dishes and incubated at 37°C in 5%
CO2 for 1 h. Once the gel was set, cells were maintained in
normal culture conditions. Gel contraction was monitored daily
by imaging the plates with a desktop scanner. The gel contrac-
tion value refers to the contraction observed after 2 d. To obtain
the gel contraction value, the relative diameters of the well and
gel were measured using ImageJ software, and the percentage of
contraction was calculated using the formula [100 × (well area −
gel area)/well area]. Data are expressed as mean ± SEM.
Generation of xenograft tumors and intravital imaging
All animals were kept in accordance with UK regulations under
project license PPL80/2368. 6–8-wk-old CD1 nude mice were
injected subcutaneously with 106 690.cl2KO-GFP or 690.cl2KO-
Cdc42ep5 murine melanoma cells suspended in 100 µl PBS/
Matrigel (50:50). Tumor size was measured every other day
using calipers. To calculate tumor volume, the formula [V =
(length × width2)/2] was used. Intravital imagingwas performed
using a confocal multiphoton inverted microscope with a mo-
torized XY scanning stage, four-channel spectral scanhead
(descanned), and two hybrid detectors (TCS SP8; Leica) when
tumors reached 6–8 mm. Tumors were excited with an 880-nm
pulsed Ti–Sapphire laser and emitted light acquired at 440 nm
(collagen second harmonic generation) and 530 nm (GFP) using
20×/0.75 NA objective lens. During ∼10-min intervals, five to
eight different regions were imaged simultaneously for 2 h for
each tumor. In each region, a z-stack of three images (∼50 µm
deep on average) was taken, resulting in a time-lapse 3D z series
for analysis. Time-lapse movies were processed and analyzed
using ImageJ, including a “3D drift correction” script. This was
achieved by converting the images obtained to hyperstacks and
correcting for drift using the static second harmonic generation
signal. The images generated were then processed to generate
movies using LAS X software. To generate colored time projec-
tions, time-lapse movies were loaded into ImageJ and the
function “Hyperstack>Temporal-Color Code” used. This gen-
erates motion analysis images by overlaying blue, green, and red
images from different time points. Distinct areas of color indi-
cate motile cells, whereas white areas indicate static regions.
Once processed, images were assessed for cell movement, cell
morphology, and cell size. Moving cells were defined as those
that moved ≥10 µm during the length of each movie, and the
moving distance and resulting speed was determined using LAS
X software.
Experimental metastasis assay
690.cl2 cells stably expressing GFP or mCherry were transfected
with control or experimental siRNA (Cdc42ep5 or Sept9), re-
spectively. 48 h after transfection, Cherry and GFP cells were
mixed in PBS at a ratio of 1:1, and 106 cells (mixed population)
were injected into the tail vein of CD1 nude mice. Mice were
culled 2 and 24 h after injection, and lungs were dissected and
placed in PBS. GFP and Cherry signal in fresh lungs were col-
lected using a Leica TCS SP8 confocal inverted microscope (20×/
0.75 NA objective lens; 12 fields of view per lung). The area of
GFP and Cherry cells was quantified using Volocity. For each
mouse, the percentage of GFP and Cherry area of both lungs was
averaged. Data are expressed as mean ± SEM from at least four
independent animals.
Time-lapse analysis and cell migration in 2D
All live-imaging experiments were performed at 37°C 5% CO2 in
normal growth medium. Time-lapse microscopy was performed
with an inverted microscope (TE 2000; Nikon) equipped with a
motorized stage, a camera (OrcaR2; Hamamatsu Photonics) and
HCImaging software. Cells were seeded at low density, and
bright-field images were captured every hour for 18 h with 20×/
0.45 NA objective lens. Individual cells were tracked using the
MTrackJ ImageJ plugin.
RNA isolation and quantitative RT-PCR
RNA was isolated using RNeasy Kit (Qiagen). Reverse tran-
scription was performed using Precision NanoScript 2 Reverse-
Transcription kit (PrimerDesign) and quantitative PCR using the
PrecisionPLUS 2x qPCR MasterMix with ROX and SybrGreen
(PrimerDesign). Expression levels of indicated genes were nor-
malized to the expression of Gapdh/GAPDH or Rplp1. Sequences
of the oligonucleotides used for quantitative RT-PCR are de-
scribed in Table S2. Data on Fig. S1 I describing the RSEM (RNA-
seq by expectation maximization) values from melanoma and
breast cancer samples were retrieved from The Cancer Genome
Atlas.
Coimmunoprecipitation
690.cl2 cells expressing the GFP-tagged plasmids of interest
were grown on 150-mm Petri dishes and lysed in lysis buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% [vol/vol] Triton X-
100, 10% [vol/vol] glycerol, 2 mM EDTA, 25 mMNaF, and 2 mM
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NaH2PO4). The resultant lysates were first precleared using IgG-
conjugated Protein G beads, incubated with the specific anti-
bodies for 2 h at 4°C, and then incubated with Protein G beads
for 1 h at 4°C with gentle mixing. Beads were then washed four
times with lysis buffer and eluted with 20 µl of 2X SDS sample
buffer.
Generation of recombinant proteins
Escherichia coli BL21(DE3) bacteria transformed with pGEX-GST-
Cdc42ep5, pnCS-Strep-SEPT6/7, or pET-28a-His-SEPT9 were
grown in LB medium at 37°C with ampicillin, spectinomycin,
and kanamycin, respectively. Protein expression was induced at
an OD600 of 0.8 with 0.5 mM IPTG for 16 h at 18°C, harvested by
centrifugation, and suspended in 50 mM Tris-HCl, pH 8,
300 mM NaCl, 1 mM PMSF, and 5 mM benzamidine. Bacteria
were sonicated four times on ice (amplitude 20%, 15 s on, 45 s
off) and centrifuged at 20,000 ×g for 30 min at 4°C. Super-
natants were collected and incubated with 400 µl of the re-
spective beads (Glutathione Sepharose, Strep-Tactin, or NiNTA
agarose) for 1 h. Beads were washed five times with two column
volumes of lysis buffer and eluted with two column volumes of
50 mM Tris-HCl, pH 8, 300 mM KCl, and 5 mM MgCl2 supple-
mented with imidazole (250 mM), glutathione (10 mM), or
desthiobiotin (2.5 mM). The eluted proteins were further puri-
fied by size-exclusion chromatography on a Superdex 200 In-
crease 10/300 GL column (GE Healthcare) in 50 mM Tris-HCl,
pH 8, 300 mM KCl, 5 mM MgCl2, and 5 mM DTT. The con-
centration of all purified proteins was determined by the
Bradford assay.
In vitro actin assays
Human non-muscle actin (Cytoskeleton) in general actin buffer
(5 mM Tris-HCl, pH 8.0, and 0.2 mM CaCl2 supplemented with
0.2 mM ATP) was polymerized using actin polymerization
buffer (50 mM KCl, 2 mMMgCl2, and 1 mM ATP) at 24°C for 1 h
to generate F-actin. This stock of F-actin was used for the
bundling and binding assay. For the bundling assay, indicated
concentrations of the different recombinant proteins (GST-
Cdc42ep5, His-SEPT9, or Strep-SEPT6/7) were incubated with
2 µM F-actin for 1 h at 24°C. Samples were centrifuged at 14,000 ×g
for 1 h at 24°C. For the F-actin–binding assay, the reaction of
actin and the different recombinant proteins was centrifuged at
150,000 ×g for 1.5 h at 24°C. For the actin polymerization assay,
actin was incubated on ice for 1 h with general actin buffer to
generate the G-actin stock. This stock was then mixed with the
actin polymerization buffer and the indicated concentrations of
the recombinant proteins at 24°C for 30 min. Samples were
centrifuged at 150,000 ×g for 1.5 h at 24°C. In all cases, equal
volumes of the supernatant and pellet fractions were resolved
using a 12% SDS-PAGE gel, stained with Coomassie brilliant
blue, and processed by Western blotting (for GST, His, and
actin) if indicated.
Western blotting
Protein lysates and immunoprecipitants were run on SDS-PAGE
gels (10% or 12%), transferred to nitrocellulose membranes, and
probed for the indicated proteins. Enhanced chemiluminescence
signal was acquired using an Azure Biosystems c600. Exposures
within the dynamic range were quantified by densitometry
using ImageJ. Antibody descriptions and working dilutions can
be found in Table S3.
Immunofluorescence
Cells were seeded on glass-bottom 24-well plates (MatTek).
Where indicated, cells were seeded in glass-bottom plates cov-
ered with 10 µg ml−1 fibronectin. For analysis of 3D morphology,
cells were seeded on top of 2.3 mg ml−1 collagen-I gel over a
glass-bottom dish (MatTek) in medium and allowed to adhere
for 24 h. Cells were fixed in 4% PFA and permeabilized in PBS
with 0.2% Triton X-100. Where indicated (i.e., septin staining)
cells were fixed in ice-cold methanol for 15 min and per-
meabilized in PBS with 0.2% Triton X-100. Samples were
blocked in 3% BSA with 0.1% PBS Tween (PBST) for 3 h. Primary
antibodies (Table S3) were diluted in 3% BSA in PBST for 2 h.
Wells were then washed three times for 10 min each in 3% BSA
PBST, followed by the addition of the appropriate secondary
(Alexa Fluor; Invitrogen). After three 15-min washes in PBS,
samples were mounted and analyzed.
Microscopy and image analysis
For morphological analyses of cells grown over collagen, a
minimum of five images were taken of cells per experiment
using 10×/0.40 NA or 20×/0.75 NA objective lenses on an in-
verted confocal microscope (TCS SP8; Leica). For analyses of
fluorescence intensity differences, microscope settings were
kept constant and independent replicates imaged on the same
day. Using phalloidin-TRITC staining and ImageJ software, in-
dividual cells were selected and the roundness coefficient ob-
tained using the circularity function [4pi (area/perimeter2)]. For
analysis of single-cell F-actin/pS19-MLC2/GFP intensity, indi-
vidual cells were selected using ImageJ software and the mean
fluorescence intensity of each channel per cell. Volocity was
used for analysis of SEPT9 cytosolic/cortical intensity; areas in
the center of the cell (excluding the nucleus) were determined
for the cytosolic region, and small regions toward the cell pe-
riphery (based on F-actin staining) were chosen to determine
the cortical region of the cell. Cytosolic/cortical areas between
samples were kept constant. The mean fluorescence intensity of
Sept9 within individual areas was determined by the software.
For analysis of actin/septin/Cdc42ep5 structures in cells on
2D, cells were stained for F-actin/Sept9 and imaged at the basal
plane using 63×/1.40 NA oil immersion objective lens (TCS SP8;
Leica). The basal perinuclear region of individual cells (based on
the DAPI signal) was identified in each cell as the perinuclear
region; the peripheral area was determined as a region close to
the cell border and not in the vicinity of the nucleus. The fluo-
rescence intensity of individual channels was determined using
Volocity in the different areas. For analyses of fluorescence in-
tensity differences, microscope settings were kept constant and
independent replicates imaged on the same day.
For analysis of FA size, cells were stained with pY118-Paxillin
antibody, imaged using a 63×/1.40 NA oil immersion objective
lens (TCS SP8microscope; Leica), and analyzed using Volocity to
determine individual FA area. To determine the maturity of FAs,
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Zyxin staining was used. A minimum of five fields of view per
repetition were imaged using 63×/1.40 NA oil immersion ob-
jective lens (TCS SP8 microscope; Leica), and cells were scored
based on the presence or absence of Zyxin adhesions.
To determine the dynamics of Cdc42ep5 and F-actin, parental
690.cl2 cells were cotransfected with GFP-Cdc42ep5 and MARS-
LifeAct. Experiments were performed at 37°C 5% CO2 in normal
growthmedium. Cells were imaged with total internal reflection
fluorescence (TIRF) microscopy with Zeiss Axio Observer Z1
microscope equipped with 63×/1.46 NA oil immersion objective
lens, motorized stage, Hamamatsu Flash 4 v3 cameras, and Sli-
debook 6.0 software (3i Imaging Solutions). Fluorescent images
were acquired every second for 60 s. Videos were rendered
using ImageJ software.
To determine FA dynamics, a stable 690.cl2-GFP-Paxillin cell
line was used. Cells were transfected with either control or RNAi
targeting Cdc42ep5. TIRF was used to visualize adhesion dy-
namics using the same equipment as before. Cells were imaged
for 10 min (one frame every 30 s). Videos were rendered using
ImageJ software. To generate colored time projections, time-
lapse movies were loaded into ImageJ and the function
“Hyperstack>Temporal-Color Code” used.
For colocalization analyses, cells were stained and imaged as
before and processed using ImageJ software using the “Coloc2
plugin” (Pearson’s R value no threshold). For each individual
cell, three independent regions of interest (perinuclear, pe-
ripheral, or encompassing a FA) were analyzed and the average
value used as the Pearson’s coefficient in that cell. Image ac-
quisition and postprocessing settings and region of interest size
were maintained constant for each condition.
Analysis of clinical datasets of melanoma
Gene expression data from previous studies (GSE3189, Talantov
et al., 2005; GSE7553, Riker et al., 2008) were retrieved from
NCBI GEO. Gene expression values for septin genes were cal-
culated as a combination of all probes available for each gene.
Briefly, all probes capturing septin gene expression on individ-
ual samples were z-score normalized. Final values of expression
for individual septin genes in each sample were calculated by
summing the z-scores of all probes available for each gene.
CDC42EP5 and some septin genes (i.e., SEPT1, SEPT3, SEPT12, and
SEPT14 for Talantov et al. and SEPT14 for Riker et al.) were not
probed in these studies and therefore were not included in the
analyses.
Statistical analysis
Statistical analyses were performed using GraphPad Prism
(GraphPad Software). When n permitted, values were tested for
Gaussian distribution using the D’Agostino–Pearson normality
test. When normality tests were not possible, data distribution
was assumed to be normal. For Gaussian distributions, paired or
unpaired two-tailed Student’s t test and one-way ANOVA with
Tukey posttest (for multiple comparisons) were performed.
Following the software recommendations, Geisser–Grenhouse
correction and Dunnett’s multiple comparisons test were applied
in paired one-way ANOVA. For non-Gaussian distributions,
Mann–Whitney and Kruskal–Wallis tests with Dunn’s posttest
(for multiple comparisons) were performed. Unless stated
otherwise, mean values and SEM are shown. Violin plots were
generated using GraphPad; in addition to showing the distri-
bution, thick dashed lines represent the median, whereas thin
dashed lines represent the upper and lower quartiles. P values <
0.05 were considered statistically significant (*, P < 0.05; **, P <
0.01; ***, P < 0.001; #, P < 0.0001; †, nonsignificant). In each
graph, the number of individual experimental points is
described.
Data and materials availability
The datasets and materials generated and/or analyzed during
the current study are available from the corresponding author
upon reasonable request. Materials may be subjected toMaterial
Transfer Agreements.
Online supplemental material
Fig. S1 shows additional information on the role of CDC42EP5 in
melanoma migration and invasion. Fig. S2 shows the effect of
CDC42EP5 on actomyosin function in cells seeded on collagen-
rich matrices. Fig. S3 provides additional information on the
modulation of cytoskeletal features by CDC42EP5. Fig. S4 shows
data on septins and melanoma aggressiveness. Fig. S5 shows
in vitro analysis of actin binding, polymerization, and bundling
by SEPT6/7, SEPT9, and Cd42ep5. Fig. S6 shows how CDC42EP5
interacts with SEPT9 to promote actomyosin activity. Video
1 shows intravital imaging of 690.cl2 cells expressing Cdc42ep5
in a living tumor. Video 2 shows intravital imaging of 690.cl2
cells lacking Cdc42ep5 in a living tumor. Video 3 shows dy-
namics of LIFEACT-RFP and GFP-Cdc42ep5 in 690.cl2 cells.
Video 4 shows GFP-Paxillin dynamics in control and Cdc42ep5-
depleted 690.cl2 cells. Table S1 describes RNAi, Table S2 de-
scribes oligonucleotides, and Table S3 describes antibodies used
in this study.
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Figure S1. CDC42EP5 is required for melanoma migration and invasion. (A) Efficacy of RNAi silencing of Borg genes in 690.cl2 cells. Graph shows fold
normalized expression of Cdc42ep1-5 (Ep1-5) against control cells (siCtr) cells when individual genes were targeted (siEp1-5). Bars indicate mean (n = 2 in-
dependent experiments). (B) Diagram showing the targeting sequence for endogenous Cdc42ep5 CRISPR/CAS9 knockout in murine wild-type 690.cl2 cells.
Underneath is the sequence of the same locus in the 690.cl2KO cells. (C)Western blot showing Cdc42ep5, GFP, and Gapdh expression in parental 690.cl2 cells
(wild-type) and in 690.cl2KO cells expressing GFP or GFP-Cdc42ep5. (D) Graph shows fold migration ability of wild-type 690.cl2 (WT) cells compared with
690.cl2KO cells expressing GFP or GFP-Cdc42ep5. Bars indicate mean ± SEM (n = 3 experiments; one-way paired ANOVA Tukey’s test; *, P < 0.05; **, P < 0.01).
(E) Graph shows migration ability of parental 690.cl2 cells ectopically expressing GFP or GFP-CDC42EP5. Bars indicate mean ± SEM (n = 3 experiments; paired
t test). (F) Graph shows fold normalized expression of Cdc42EP5 in human WM266.4 and MDA-MB-231-LM2 cells after transfection with control (siCtr) and
CDC42EP5 (siEP5) siRNAs. Bars indicate mean (n = 2 independent experiments). (G and H) Graphs show fold migration ability (G) and 3D invasion (H) of
WM266.4 and MDA-MB-231 cells after transfection with control (siCtr) and CDC42EP5 (siEP5) siRNAs. Bars indicate mean ± SEM (n = 3 experiments [G] and 4
[H]; paired t tests). (I and J) Graphs show expression of Borg genes (CDC42EP1-5, EP1-5) in the indicated cell lines (I) and databases (J). Expression levels in
690.cl2, WM266.4, and MDA-MB-231-LM2 were normalized against expression of Rplp1 and GAPDH, as indicated. Expression levels in melanoma and breast
cancer were obtained from The Cancer Genome Atlas and expressed in RSEM (RNA-seq by expectation maximization). (K) Cell proliferation curves of 690.cl2KO
cells ectopically expressing GFP (KO) or GFP-Cdc42EP5 (KO-EP5). Lines indicate mean ± SEM (n = 3 experiments). (L) Graph shows quantification of volumes at
day 7 post-injection of subcutaneous tumors induced by injection of 690.cl2KO cells expressing GFP or GFP-Cdc42ep5. Bars indicate mean ± SEM (n = 6 mice;
paired t test). KO, knockout.
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Figure S2. CDC42EP5 promotes actomyosin function in collagen-rich matrices. (A) Images of 690.cl2 cells expressing GFP-Cdc42ep5 (green) on collagen-
rich matrices. Merged and single greyscale channels also show F-actin (magenta) and pS19-MLC2 (cyan) staining. Scale bar, 50 µm. Violin plots show pS19-
MLC2 (left) and F-actin (right) mean intensity from individual cells in 690.cl2 cells expressing different levels of Cdc42ep5 (high or low). n, individual cells;
Mann–Whitney test. (B) Top panels represent the different shape of individual 690.cl2 cells and their respective roundness index. Left graph shows a violin plot
of the roundness index of individual cells in 690.cl2 cells expressing different levels of Cdc42ep5 (high or low). n, individual cells; Mann–Whitney test. Right
graph shows the relative frequencies of roundness indexes in Cdc42ep5hi and Cdc42ep5lo 690.cl2 cells. (C) Graph shows the relative frequencies of roundness
indexes in 690.cl2 cells after transfection with control (siCtr) or two individual Cdc42ep5 (siEp5) siRNAs (additional representation of Fig. 2 C). (D) Graph shows
the percentage of cells within three different ranges of roundness, from elongated (<0.4) to rounded (>0.6), in 690.cl2 cells after transfection with control
(siCtr) or two individual Cdc42ep5 (siEp5) siRNAs. Bars represent mean. Additional representation of Figs. 2 C and S2 D. (E) Graphs show expression of
CDC42EP1, CDC42EP2, CDC42EP3, and CDC42EP4 normalized to GAPDH expression in human melanoma cell lines with increasing rounding coefficients.
Pearson’s correlation coefficient (r), statistical significance (p), and linear regression (red line) are shown. Each point in the graph represents the mean value of
three independent experiments. (F) Western blot of indicated proteins in 690.cl2 cells after transfection with control (siCtr) and siRNAs targeting individual
Borg genes (siEp1–5). Graph shows the quantification of normalized pS19-MLC2 levels in the different experimental points. Bars indicate mean ± SEM (n = 7
experiments; one-way paired ANOVA, Dunnett’s test: †, not significant; *, P < 0.05). AU, arbitrary units.
Farrugia et al. Journal of Cell Biology S3




 http://rupress.org/jcb/article-pdf/219/9/e201912159/1048538/jcb_201912159.pdf by guest on 20 August 2020
Figure S3. CDC42EP5 modulates cytoskeletal features. (A) Image showing acetylated tubulin (red), GFP (green) and DAPI (blue) in 690.cl2 expressing GFP-
Cdc42ep5 on glass. Right panels show single greyscale channel magnifications of the indicated area. Scale bars, 12.5 µm. (B) Images show F-actin (magenta),
GFP (green), pS19-MLC2 (cyan), and DAPI (gray) signal of 690.cl2 cells stably expressing GFP-Cdc42ep5 on glass. Top panels showmerged channel images of a
protrusion (left) and perinuclear areas (basal, middle panel; apical, right panel). Bottom right inserts show whole-cell images. Lower panels show individual
grayscale channels for the indicated regions and signals. Scale bars, 10 µm. (C) Images show F-actin (magenta) and DAPI (blue) staining of mouse embryonic
fibroblasts (MEFs; top panels) and human melanoma cells (WM266.4, lower panels) on glass after transfection with control (siCtr) and CDC42EP5 (siEP5)
siRNA. Grayscale magnifications of F-actin staining in indicated perinuclear areas are shown. Scale bars, 12.5 µm. Violin plot shows perinuclear F-actin in-
tensity. n, single regions from individual cells; Mann–Whitney test: #, P < 0.0001. (D) Images of 690.cl2 cells after transfection with control (siCtr) and
Cdc42ep5 (siEp5#1&3) siRNA on glass. Images show F-actin (magenta), Zyxin (green), and DAPI (blue) staining. Right panels show greyscale Zyxin channel
magnifications. Scale bars, 12.5 µm. Graph shows percentage of cells with Zyxin-positive FAs for cells seeded on glass or on fibronectin. Bars indicate mean ±
SEM (n = 4 experiments; unpaired t tests: #, P < 0.0001). (E) Plots show single-cell trajectories of 690.cl2 cells after transfection with control (siCtr) and two
individual Cdc42EP5 (siEP5#1 and siEP5#3) siRNAs on 2D surfaces. Violin plot shows speed of individual cells. n, individual cells; Kruskal–Wallis and Dunn’s
tests: *, P < 0.05; #, P < 0.0001. (F) Western blots show pY438-Src and tubulin levels in 690.cl2 cells after transfection with control (siCtr) and siRNAs
targeting individual Borg genes (siEp1–5). Graph shows the quantification of normalized pY418-Src levels. Bars indicate mean ± SEM (n = 5 experiments; one-
way paired ANOVA, Dunnett’s test: †, not significant; ***, P < 0.001). AU, arbitrary units.
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Figure S4. SEPT9 is associated with melanoma aggressiveness. (A and B) Violin plots showing the expression of available septin genes in human tissues
from normal skin, nevus, and melanoma from the Talantov et al. dataset (GSE3189; A) and primary melanoma and metastatic melanoma from the Riker et al.
dataset (GSE7553; B). n, individual patients; Kruskal–Wallis and Dunn’s tests (A) and Mann–Whitney tests (B): †, not significant; *, P < 0.05; **, P < 0.01; ***, P <
0.001; #, P < 0.0001. (C) Graph showing quantification of normalized protein expression levels of Sept2, Sept7, and Sept9 in 690.cl2 cells after transfection
with control (siCtr) or Sept2, Sept7, or Sept9 siRNAs. Bars indicate mean ± SEM (n = 3 experiments; two-way ANOVA Dunnett’s test: †, not significant; *, P <
0.05). Representative Western blot is shown in Fig. 4 B. (D) Graph shows the relative frequencies of roundness indexes in 690.cl2 cells after transfection with
control (siCtr) or Sept2, Sept7, or Sept9 siRNA on collagen-rich matrices (additional representation of Fig. 4 D). (E) Top panels showmorphologies of WM266.4
after transfection with control (siCtr) or SEPT9 (siSEPT9) siRNA on top of collagen-rich matrices. Scale bars, 20 µm. Left bottom graph shows roundness index
quantification of individual cells (n indicates individual cells; Mann–Whitney test). Right bottom graph shows the relative frequencies of roundness indexes.
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Figure S5. CDC42EP5 potentiates the F-actin bundling activities of SEPT9. (A) Coomassie-stained gel showing equal volumes of supernatant (S) and pellet
(P) fractions from low-speed sedimentation of prepolymerized actin filaments in the presence of different concentrations of recombinant SEPT9 (as indicated).
(B) Coomassie-stained gel showing equal volumes of supernatant (S) and pellet (P) fractions from low-speed sedimentation of prepolymerized actin filaments
in the presence of recombinant Cdc42ep5 (1 µM), SEPT6/7 (1 µM), and both Cdc42ep5 (1 µM) and SEPT6/7 (1 µM). (C) Top panel is a Coomassie-stained gel
showing equal volumes of supernatant (S) and pellet (P) fractions from high-speed sedimentation assays (F-actin–binding assays) in the presence of re-
combinant Cdc42ep5 (1 µM) and SEPT9 (1 µM). Bottom panel shows anti-actin, anti-GST (Cdc42ep5), and anti-His (SEPT9) Western blots of the same ex-
periment. SEPT9 only appears in the pellet (high interaction with F-actin), whereas Cdc42EP5 is primarily found in the supernatant (low interaction with
F-actin). (D) Top panel is a Coomassie-stained gel showing equal volumes of supernatant (S) and pellet (P) fractions from an actin polymerization assay in the
presence of recombinant Cdc42ep5 (1 µM), SEPT9 (1 µM), and both Cdc42ep5 (1 µM) and SEPT9 (1 µM). Bottom panel shows an anti-Actin Western blot of the
same experiment. Graph shows the actin polymerization coefficient (ratio of actin in pellet vs supernatant) in the indicated experimental points. Bars indicate
mean ± SEM (n = 3 experiments; one-way ANOVA, Tukey’s test: †, not significant; *, P < 0.05).
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Figure S6. CDC42EP5 interacts with SEPT9 to promote actomyosin activity. (A) Western blot showing Sept9 and GFP levels in total lysates (input) and
anti-GFP immunoprecipitates (IP:GFP) in 690.cl2 cells ectopically expressing GFP, GFP-Cdc42ep5WT, and GFP-Cdc42ep5GPS-AAA. (B) Western blot showing
Cdc42ep5 and Gapdh expression in parental 690.cl2 cells (wild-type) and 690.cl2KO cells expressing GFP, GFP-Cdc42ep5WT, or GFP-Cdc42ep5GPS-AAA.
(C) Images show GFP (green), Sept9 (blue), and F-actin (magenta) in 690.cl2KO cells expressing GFP, GFP-Cdc42ep5WT, or GFP-Cdc42ep5GPS-AAA on glass.
Bottom panels are merged and single-channel magnifications of perinuclear areas. Scale bars, 20 µm. Violin plot in the right shows perinuclear Sept9 mean
intensity in the indicated cells. n, individual cells; Kruskal–Wallis and Dunn’s tests: †, not significant; #, P < 0.0001. (D) Graph shows the relative frequencies of
roundness indexes in 690.cl2KO cells expressing GFP, GFP-Cdc42ep5WT or GFP-Cdc42ep5GPS-AAA on collagen-rich matrices (additional representation of Fig. 6
C). (E)Western blot showing pS19-MLC2 and Sept2 expression in 690.cl2KO cells expressing GFP, GFP-Cdc42ep5WT, or GFP-Cdc42ep5GPS-AAA. Graph shows the
normalized pS19-MLC2 levels. Bars indicate mean ± SEM (n = 3 experiments; one-way ANOVA, Tukey’s test: †, not significant; *, P < 0.05; **, P < 0.01).
(F) Graph shows the relative frequencies of roundness indexes in 690.cl2KO cells expressing GFP or GFP-SEPT9_V1 on collagen-rich matrices (additional
representation of Fig. 6 F). AU, arbitrary units; KO, knockout.
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Video 1. Intravital imaging of 690.cl2 cells expressing Cdc42ep5 in a living tumor. 690.cl2KO cells ectopically expressing GFP-Cdc42ep5 (green) were
grown subcutaneously and imaged in vivo using two-photon microscopy, which enabled the acquisition of a second harmonic signal (collagen fibers, magenta).
Images were acquired every 14 min for a total of 2 h 45 min. Scale bar, 100 µm. Middle panels show magnifications of indicated areas showing fast amoeboid
movement into the matrix. Right panels represent motion analysis images of the same area generated by overlaying blue, green, and red images from different
time points. Distinct areas of color indicate motile cells, whereas static regions appear white.
Video 2. Intravital imaging of 690.cl2 lacking Cdc42ep5 in a living tumor. 690.cl2KO cells ectopically expressing GFP (green) were grown subcutaneously
and imaged in vivo using two-photon microscopy, which enabled the acquisition of a second harmonic signal (collagen fibers, magenta). Images were acquired
every 14 min for a total of 2 h 45 min. Scale bar, 100 µm. Middle panels showmagnifications of indicated areas showing slow protrusive movement of cells and
elongated morphology. Right panels represent motion analysis images of the same area generated by overlaying blue, green, and red images from different
time points. Distinct areas of color indicate motile cells, whereas static regions appear white.
Video 3. Dynamic association between F-actin and CDC42EP5. Time-lapse movie of a 690.cl2 cell expressing LIFEACT-RFP (magenta) and GFP-Cdc42ep5
(green). The cell was seeded on glass and imaged every 1 s (60 s total). Right panels show merged and single-channel magnifications (greyscale) of peripheral
and perinuclear and peripheral regions.
Video 4. CDC42EP5 regulates FA dynamics. Time-lapse movies of a 690.cl2 cell expressing GFP-Paxillin (gray) after transfection with control (siCtr) or
Cdc42ep5 (siEP5) siRNA. The cell was seeded on glass and imaged every 30 s (10 min total). Lower panels represent motion analysis images of the same areas
generated by overlaying blue, green, and red images from different time points.
Provided online are three tables. Table S1 describes RNAi, Table S2 describes oligonucleotides, and Table S3 describes antibodies
used in this study.
Farrugia et al. Journal of Cell Biology S8




 http://rupress.org/jcb/article-pdf/219/9/e201912159/1048538/jcb_201912159.pdf by guest on 20 August 2020
